Campaign run · Parkinson's disease
parkinson-scenic-regulons-r1
Which transcription-factor (TF) regulons, inferred de novo by pySCENIC from the Fullard 2024 multi-region snRNA-seq atlas (CELLxGENE d5d0df8f-...) on substantia-nigra pars compacta (SNpc) dopaminergic (DA) neurons, are differentially active between Parkinson's-disease (PD) and age-matched control donors — and do those regulon-activity shifts replicate in the independent Smajic / Wang / Adams SNpc atlases when the same regulon dictionary is scored zero-shot via AUCell?
Status
- How far it got
- Completed the pipeline
Tested at least one hypothesis and reached the multi-agent review stage. This shows the run went through the whole pipeline, not that its work passed a quality bar.
- Hypotheses
5 nominated; 5 evaluated.
- Recorded status
Halted. The run recorded a final status of halted: it was closed without being marked done. A halted run can still have tested hypotheses and written a final report.
- Census class
Success. Census class is a label from an earlier, process-level census of the campaign. It does not map one-to-one onto the stages above. How the classes compare.
Research question
The sentence under the run id is quoted from this brief.
Full research brief given to the run
Which transcription-factor (TF) regulons, inferred de novo by pySCENIC from the Fullard 2024 multi-region snRNA-seq atlas (CELLxGENE d5d0df8f-...) on substantia-nigra pars compacta (SNpc) dopaminergic (DA) neurons, are differentially active between Parkinson's-disease (PD) and age-matched control donors — and do those regulon-activity shifts replicate in the independent Smajic / Wang / Adams SNpc atlases when the same regulon dictionary is scored zero-shot via AUCell?
Selective-vulnerability biology in PD has so far been read at the cluster + marker-gene resolution (Kamath 2022 AGTR1+; Wang 2024 RIT2+/CALB1-). The TF-network layer above the markers has not been formally tested for cross-atlas reproducibility — i.e., is the dysregulation a coherent regulon shift, or only an apparent marker-gene shift that scrambles when the network is recomputed from a different atlas? This OmiCairn run pre-registers that test.
Hypotheses (pre-registered):
H1 (primary — regulon replication across three independent atlases): Let R = the top-20 SNpc-DA PD-vs-control differentially active regulons in the Fullard atlas (FDR < 0.05, limma-voom on the donor × regulon-AUCell matrix with age + sex + post-mortem interval covariates). At least 3 of those 20 regulons recover a same-sign log-fold-change in regulon- AUCell score in all three held-out atlases (Smajic GSE157783, Wang GSE184950, Adams GSE193688), with a binomial test p < 0.01 against a null of 0.5 sign-agreement for each regulon × atlas combination.
H2 (secondary — TF gene-level GWAS enrichment): The PD-up-regulated regulon set (FDR < 0.05 in Fullard, same-sign in ≥ 2 of 3 replication atlases) is enriched by hypergeometric test (q < 0.05) for TFs whose genes carry PD-risk fine-mapped variants in the Kim 2024 multi-ancestry GWAS (GCST90275127 Supplementary Table S5).
H3 (secondary — alignment with AGTR1+ depletion): Per-donor AUCell scores of the consensus PD-up regulons rank-correlate (Spearman ρ > 0.3, p < 0.05) with the AGTR1+ DA depletion score derived in the v1 parkinson-da-vulnerability workspace (read from prior workspace results record), at the donor level inside Fullard SNpc.
H4 (secondary — donor-level classification): Leave-one-atlas-out donor-level random forest using only the top-50 SNpc DA regulon AUCell scores as features achieves an AUC ≥ 0.70 for PD-vs-control classification (95% bootstrap CI excluding 0.5).
H5 (secondary — clustering-resolution robustness): Re-run the top-level Leiden clustering at γ ∈ {0.4, 0.8, 1.2}; the H1 same-sign replication count varies by ≤ 1 regulon across the three resolutions (the dominant failure mode the v1 parkinson-da-vulnerability case logged).
Null payoff. If consensus regulons fail to replicate across atlases (H1 = 0/20 same-sign in ≥ 2 atlases), the field's TF-level mechanistic claim is at the cluster-resolution layer, not the regulon-network layer. That is an informative Tier-A negative.
The research question comes from the topic's current research brief. All attempts at a topic share it; earlier attempts may have started from an earlier wording.
Hypotheses and verdicts
Each hypothesis was written with its decision rule before any analysis (or, for on-the-fly hypotheses, recorded during execution). AI adjudication agents applied that rule to the run's latest outputs and quoted the evidence verbatim. Where the data did not meet the rule, the verdict follows the data, even if the run's own label or report claimed support.
| ID | Hypothesis and decision rule | Verdict |
|---|---|---|
| H1Pre-registered | Top-20 Fullard SNpc-DA PD regulons replicate same-sign in all 3 held-out atlases (>=3 regulons) with binomial p<0.01 | InconclusiveIn the explorer |
Evidence (verbatim from the run outputs) 3/20 TFs (15%) show sign agreement in both — no better than a null of 50% sign-agreement per pair (binomial p = 0.785) Adjudication note Pre-registered design not executable: Fullard SNpc discovery atlas unavailable (Adams n=4 PD used), CollecTRI/ULM instead of pySCENIC/AUCell, 2 of 3 replication atlases. Chance-level result (p vs shuffled 0.919); run calls it 'inconclusive rather than falsified' / underpowered. stage 4 (basis of the report) gave 9/20 in 1 atlas, p=0.748. Arguably NOT_TESTED_DATA (proxy test). | ||
| H2Pre-registered | Consensus PD-up regulon TFs enriched (BH q<0.05) for Kim 2024 fine-mapped PD-risk genes | Not testableIn the explorer |
Evidence (verbatim from the run outputs) This is a proxy test, not the pre-registered test. Conclusion about H2 is inconclusive pending the actual Kim 2024 supplementary table. Adjudication note Kim 2024 fine-mapping table not retrieved; OpenTargets proxy gave 0 overlaps, q=1.0 (run labelled NOT_SUPPORTED). | ||
| H3Pre-registered | Per-donor consensus PD-up regulon activity correlates (rho>0.3) with AGTR1+ DA depletion | Not testableIn the explorer |
Evidence (verbatim from the run outputs) INAPPLICABLE. Prior workspace Adjudication note None recorded. | ||
| H4Pre-registered | Leave-one-atlas-out RF on regulon scores classifies PD donors with mean AUC>=0.70 and CI excluding 0.5 | InconclusiveIn the explorer |
Evidence (verbatim from the run outputs) Mean AUC = 0.808 meets the ≥ 0.70 threshold, but the pre-registration criterion required CI lower bound > 0.5. With only 2 LOO folds, bootstrap CI lower bound = 0.25 (< 0.5). Adjudication note Run labels NOT_SUPPORTED; 2 folds/16 donors instead of 4-fold LOO, CI [0.25,1.0] uninformative (run attributes to data limitation). Could be NOT_SUPPORTED by the letter of the rule. | ||
| H5Pre-registered | H1 replication count varies by <=1 across Leiden gamma 0.4/0.8/1.2 | SupportedIn the explorer |
Evidence (verbatim from the run outputs) SUPPORTED. Swing = 1 ≤ pre-registered threshold of 1. Adjudication note Robustness of a chance-level count (2-3/20); report (stage 4 data) reported swing=0. | ||